Literature DB >> 1659618

ACTH and cortisol secretion in patients with Alzheimer's disease.

M Franceschi1, L Airaghi, C Gramigna, G Truci, M G Manfredi, N Canal, A Catania.   

Abstract

The "glucocorticoid cascade hypothesis" for pathological ageing of the brain is supported by strong experimental data, but the clinical correlates are far less clear. The basal ACTH and cortisol secretion have been studied before and after the dexamethasone suppression test in patients in the early stages of clinically probable Alzheimer's disease and in controls, and the results were all normal. These findings do not support the hypothesis that the pathological brain ageing of Alzheimer's type is caused by hyperactivity of the pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659618      PMCID: PMC1014528          DOI: 10.1136/jnnp.54.9.836

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Pharmacological modulation of cortisol secretion and dexamethasone suppression in Alzheimer's disease.

Authors:  P Davous; M Roudier; M L Piketty; C Abramowitz; Y Lamour
Journal:  Biol Psychiatry       Date:  1988-01-01       Impact factor: 13.382

2.  Tests of hypothalamic-pituitary-adrenal function in man.

Authors:  H S Jacobs; J D Nabarro
Journal:  Q J Med       Date:  1969-10

Review 3.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

Authors:  R M Sapolsky; L C Krey; B S McEwen
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

4.  Does severity of dementia modulate response to dexamethasone in individuals with primary degenerative dementia?

Authors:  N Pomara; G F Oxenkrug; I M McIntyre; R Block; M Stanley; S Gershon
Journal:  Biol Psychiatry       Date:  1984-10       Impact factor: 13.382

5.  Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications.

Authors:  R M Sapolsky; W A Pulsinelli
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

6.  Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity.

Authors:  S Feldman; N Conforti
Journal:  Neuroendocrinology       Date:  1980       Impact factor: 4.914

7.  Dexamethasone suppression test and serum prolactin in dementia disorders.

Authors:  J Balldin; C G Gottfries; I Karlsson; G Lindstedt; G Långström; J Wålinder
Journal:  Br J Psychiatry       Date:  1983-09       Impact factor: 9.319

8.  Effects of chronic medical illness and dementia on the dexamethasone suppression test.

Authors:  M Carnes; J C Smith; N H Kalin; S F Bauwens
Journal:  J Am Geriatr Soc       Date:  1983-05       Impact factor: 5.562

9.  Dexamethasone suppression in dementia, depression, and normal aging.

Authors:  A Georgotas; R E McCue; O M Kim; W E Hapworth; B Reisberg; P M Stoll; E Sinaiko; C Fanelli; P E Stokes
Journal:  Am J Psychiatry       Date:  1986-04       Impact factor: 18.112

10.  Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia.

Authors:  M Raskind; E Peskind; M F Rivard; R Veith; R Barnes
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

View more
  6 in total

1.  Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease.

Authors:  Jiapei Dai; Ruud Buijs; Dick Swaab
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

Review 2.  Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis.

Authors:  Cheryl D Conrad
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

Review 3.  Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease.

Authors:  Jennifer A Ross; Gediminas Gliebus; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-10       Impact factor: 5.201

4.  Therapeutic approaches to age-associated neurocognitive disorders.

Authors:  R O'Hara; C Derouesné; K N Fountoulakis; J A Yesavage
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

Review 5.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

Review 6.  Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress.

Authors:  Kanchan Bisht; Kaushik Sharma; Marie-Ève Tremblay
Journal:  Neurobiol Stress       Date:  2018-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.